Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 105, Issue 6, Pages 1367-1373Publisher
WILEY
DOI: 10.1002/jcb.21935
Keywords
TGF-beta 1; VEGF; VEGF RECEPTOR-2; VE-CADHERIN; BETA-CATENIN; ENDOTHELIAL CELLS; ADHERENS JUNCTION
Categories
Funding
- NIH [R01 HL070203, R01 HL070203-03S1]
- Department of Cardiothoracic Surgery of NYU School of Medicine
Ask authors/readers for more resources
VEGF and TGF-beta 1 induce angiogenesis but have opposing effects on vascular endothelial cells: VEGF promotes survival; TGF-beta 1 induces apoptosis. We have previously shown that TGF-beta 1 induces endothelial cell apoptosis via up-regulation of VEGF expression and activation of signaling through VEGF receptor-2 (flk-1). In context with TGF-beta 1, VEGF signaling is transiently converted from a survival into an apoptotic one. VEGF promotes cell survival in part via activation of PI3K/Akt by a mechanism dependent on the formation of a multi-protein complex that includes flk-1 and the adherens junction proteins VE-cadherin and beta-catenin. Here we report that TGF-beta 1 induces rearrangement of the adherens junction complex by separating flk-1 from VE-cadherin and increasing beta-catenin association with both flk-1 and VE-cadherin. This rearrangement is caused neither by changes in adherens junction mRNA or protein expression nor by post-translational modification, and requires VEGF signaling through flk-1. These results show that the adherens junction is an important regulatory component of TGF-beta 1-VEGF interaction in endothelial cells. J. Cell. Biochem. 105: 1367-1373, 2008. (C) 2008 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available